Cash and cash equivalents (In thousands)

Accounts receivable, net (In thousands)

Inventories (In thousands)

Prepaid expenses (In thousands)

Income taxes receivable (In thousands)

Other current assets (In thousands)

TOTAL CURRENT ASSETS (In thousands)

PROPERTY, PLANT AND EQUIPMENT, net (In thousands)

RIGHT OF USE ASSETS (In thousands)

INTANGIBLES, net (In thousands)

GOODWILL (In thousands)

DEFERRED TAX ASSETS, net (In thousands)

OTHER ASSETS (In thousands)

TOTAL ASSETS (In thousands)

Accounts payable (In thousands)

Accrued payroll and related costs (In thousands)

Taxes other than payroll and income (In thousands)

Unearned revenues (In thousands)

Operating lease liabilities (Current) (In thousands)

Income taxes payable (In thousands)

Other current liabilities (In thousands)

TOTAL CURRENT LIABILITIES (In thousands)

LONG-TERM DEBT, net (In thousands)

LONG-TERM OPERATING LEASE LIABILITIES (In thousands)

DEFERRED COMPENSATION (In thousands)

DEFERRED TAX LIABILITIES, net (In thousands)

OTHER LONG-TERM LIABILITIES (In thousands)

Preference stock (In thousands)

Common stock (In thousands)

Additional paid-in capital (In thousands)

Retained earnings (In thousands)

Accumulated other comprehensive income (loss) (In thousands)

Treasury stock (at cost) (In thousands)

Total Core Laboratories Inc. shareholders' equity (In thousands)

Non-controlling interest (In thousands)

TOTAL EQUITY (In thousands)

TOTAL LIABILITIES AND EQUITY (In thousands)

b5df8c21ec90b0ed54d2ce606b90543366b82b211b706083267b33237854e1aa

Total Revenue (USD, thousands)

Services Revenue (USD, thousands)

Product sales Revenue (USD, thousands)

Other (income) expense, net (USD, thousands)

OPERATING INCOME (USD, thousands)

Interest expense (USD, thousands)

Income before income taxes (USD, thousands)

Income tax expense (benefit) (USD, thousands)

Net income (USD, thousands)

Net income attributable to non-controlling interest (USD, thousands)

Net income (loss) attributable to Core Laboratories Inc. (USD, thousands)

Basic earnings per share (USD)

Basic earnings per share attributable to Core Laboratories Inc. (USD)

Diluted earnings per share (USD)

Diluted earnings (loss) per share attributable to Core Laboratories Inc. (USD)

Weighted average common shares outstanding - Basic (shares)

Weighted average common shares outstanding - Diluted (shares)

ff3d2ac4e27157058e86808a78ca89f447ad0e014764b15b995fac8a75f3c52e

Net Income (USD, thousands)

Stock-based compensation (USD, thousands)

Depreciation and amortization (USD, thousands)

Deferred income taxes (USD, thousands)

Accounts receivable (Change, USD, thousands)

Inventories (Change, USD, thousands)

Accounts payable (Change, USD, thousands)

Assets write-down (USD, thousands)

Inventory write-off and obsolescence (USD, thousands)

Changes in value of life insurance policies (USD, thousands)

Other non-cash items (USD, thousands)

Prepaid expenses and other current assets (Change, USD, thousands)

Other assets (Change, USD, thousands)

Accrued expenses (Change, USD, thousands)

Unearned revenues (Change, USD, thousands)

Other liabilities (Change, USD, thousands)

Net cash provided by operating activities (USD, thousands)

Capital expenditures - operations (Investing) (USD, thousands)

Capital expenditures - rebuilding of Aberdeen facility (Investing) (USD, thousands)

Patents and other intangibles (Investing) (USD, thousands)

Proceeds from sale of assets (Investing) (USD, thousands)

Proceeds from insurance recovery (Investing) (USD, thousands)

Net proceeds on life insurance policies (Investing) (USD, thousands)

Net cash provided by (used in) investing activities (USD, thousands)

Repayment of long-term debt (Financing) (USD, thousands)

Proceeds from long-term debt (Financing) (USD, thousands)

Debt issuance costs (Financing) (USD, thousands)

Equity related transaction costs (Financing) (USD, thousands)

Dividends paid (Financing) (USD, thousands)

Repurchase of common stock (Financing) (USD, thousands)

Other financing activities (Financing) (USD, thousands)

Net cash used in financing activities (USD, thousands)

Net change in cash and cash equivalents (USD, thousands)

Cash payments for interest (Supplemental) (USD, thousands)

Cash payments for income taxes (Supplemental) (USD, thousands)

Capital expenditures incurred but not paid for as of the end of the period (Supplemental) (USD, thousands)

Equity related transaction costs incurred but not paid for as of the end of the period (Supplemental) (USD, thousands)

Cash and cash equivalents, beginning of period (USD, thousands)

Cash and cash equivalents, end of period (USD, thousands)

cda7ca5c0961dbfd30259e429ebfed2c0f76deeb0598a80a9855ab33f04d084f

Baker Hughes Worldwide Average Rig Count (rigs)

Baker Hughes U.S. Average Rig Count (rigs)

Baker Hughes U.S. Land-based Average Rig Count (rigs)

Baker Hughes Worldwide Year-End Rig Count (rigs)

Baker Hughes U.S. Year-End Rig Count (rigs)

Baker Hughes U.S. Land-based Year-End Rig Count (rigs)

Average Crude Oil Price per Barrel WTI (USD per barrel)

Average Crude Oil Price per Barrel Brent (USD per barrel)

Average Natural Gas Price per MMBtu (USD per MMBtu)

Year-end Crude Oil Price per Barrel WTI (USD per barrel)

Year-end Crude Oil Price per Barrel Brent (USD per barrel)

Year-end Natural Gas Price per MMBtu (USD per MMBtu)

0e53336b20426f1f72b84e2ebf2a913c72695176ee43a827740abf28e29ec53d

Current Assets (USD, thousands)

Cash and Cash Equivalents (USD, thousands)

Accounts Receivable (USD, thousands)

Inventory (USD, thousands)

Non-Current Assets (USD, thousands)

Property, Plant, and Equipment (PP&E) (USD, thousands)

Goodwill (USD, thousands)

Intangible Assets (USD, thousands)

Current Liabilities (USD, thousands)

Accounts Payable (USD, thousands)

Short-term Debt (USD, thousands)

Accrued Expenses (USD, thousands)

Non-Current Liabilities (USD, thousands)

Long-term Debt (USD, thousands)

Lease Liabilities (USD, thousands)

Deferred Tax Liabilities (USD, thousands)

Shareholders' Equity (USD, thousands)

Retained Earnings (USD, thousands)

Common Stock (USD, thousands)

Additional Paid-in Capital (USD, thousands)

91dcbd69cd2893bfc6bcce5af56c5d4b705df95dbadef875db9e70628dbb1993

United States

Europe/Africa/Middle East

Asia Pacific

Canada

Former Soviet Union

Latin/South America

- Other Countries (Combined)

Total Revenue

94d6b8478cfb0eb1a16a1c6fb2d36a145af1ae08b758d1943c71fd25455cc75e

Cost of Goods Sold (COGS) (USD, thousands)

Selling, General, and Administrative Expenses (SG&A) (USD, thousands)

Research and Development (R&D) (USD, thousands)

Depreciation and Amortization (D&A) (USD, thousands)

Interest Expense (USD, thousands)

Operating Income (EBIT) (USD, thousands)

Earnings Per Share (EPS) - Basic (USD)

Earnings Per Share (EPS) - Diluted (USD)

f589b151ce2b6e1bc4eeee833a9828f6cf4e4bf78ed434a2ce40ba899c2ed9f4

Reservoir Description

- Services

- Product Sales

Production Enhancement

Services

Product Sales

870e5150e947f37bbf56734a192a0b3e267c5aac51e9735408b923c563965d9c

Adjustments for Non-Cash Items (USD, thousands)

Stock-Based Compensation (USD, thousands)

Changes in Working Capital (USD, thousands)

Capital Expenditures (CapEx) (USD, thousands)

Proceeds from / Repayments of Debt (USD, thousands)

Share Repurchases (USD, thousands)

Dividend Payments (USD, thousands)

Net Change in Cash (USD, thousands)

760cc64bbc61a41195882ce3b5979dac109f7b4abf8c907df55dd99da941cb4b

Core Laboratories Inc. /DE/ (CLB)

Financials